Valuation Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 01:20:00 19/09/26 am AEST			5-day change	1st Jan Change
40.50 ^DKK	+2.66%		-7.53%	+11.88%

11/09	Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome	MT
11/09	Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	41,777	-	-
Change	-	24.72%	24.27%	5.03%	0.92%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	45,780	41,599	37,840
Change	-	12.91%	66.4%	-3.84%	-7.74%	-9.13%	-9.04%
P/E	13.5x	14.2x	13x	13.4x	9.37x	9.18x	9.78x
PBR	1.24x	1.47x	1.64x	1.72x	1.48x	1.33x	1.22x
PEG	-	0.7x	0.3x	8.5x	0.2x	4.37x	-1.59x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	1.61x	1.6x	1.64x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	1.77x	1.6x	1.49x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	5.59x	5.11x	4.88x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	7.45x	6.64x	6.43x
EV / FCF	10.2x	8.66x	18.7x	10.2x	7.62x	6.85x	6.77x
FCF Yield	9.83%	11.5%	5.35%	9.8%	13.1%	14.6%	14.8%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.552	1.404	1.504
Rate of return	2.23%	2.14%	2.3%	2.66%	3.65%	3.3%	3.53%
EPS ²	1.93	2.31	3.17	3.22	4.54	4.635	4.35
Distribution rate	30.1%	30.3%	30%	35.7%	34.2%	30.3%	34.6%
Net sales ¹	18,246	19,912	22,004	24,630	25,908	26,032	25,462
EBITDA ¹	4,663	5,652	6,347	7,881	8,194	8,137	7,754
EBIT ¹	2,852	3,195	3,270	5,275	6,141	6,269	5,884
Net income ¹	1,916	2,290	3,143	3,192	4,581	4,657	4,391
Net Debt ¹	2,031	-711	12,182	8,221	4,003	-177.7	-3,937
Reference price ²	26.05	32.76	41.32	43.16	42.56	42.56	42.56
Nbr of stocks (in thousands)	992,840	992,840	992,011	991,227	991,227	-	-
Announcement Date	7/2/23	7/2/24	5/2/25	4/2/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MCKESSON CORPORATION	22.42x	0.25x	14.09x	0.42%	102B
CARDINAL HEALTH, INC.	22.03x	0.21x	12.4x	0.93%	52.42B
SIGMA HEALTHCARE LIMITED	33.84x	2.54x	22.92x	1.79%	20.85B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	10.48x	0.19x	4.37x	2.88%	7.88B
HUADONG MEDICINE CO., LTD	12.68x	0.9x	7.44x	3.13%	6.83B
H. LUNDBECK A/S	9.37x	1.77x	5.59x	3.65%	6.41B
SINOPHARM GROUP CO. LTD.	5.36x	0.08x	2.36x	5.53%	5.97B
GALENICA AG	24.58x	1.12x	14.13x	3.12%	4.94B
MEDIPAL HOLDINGS CORPORATION	12.9x	-	-	2.57%	3.79B
Average	17.07x	0.88x	10.41x	2.67%	23.45B
Weighted average by Cap.	21.69x	0.55x	13.36x	1.2%